Jun 18, 2025 8:32 am EDT Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group
Jun 17, 2025 2:55 pm EDT Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy
May 19, 2025 5:30 pm EDT Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results
Mar 20, 2025 7:00 am EDT Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
Feb 24, 2025 7:00 am EST Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives
Feb 5, 2025 7:00 am EST Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device
Jan 15, 2025 7:00 am EST Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders